Table 3.
Univariate DSS for Gastric
| N (#events) | HR | [95% CI] | p-value | |||
|---|---|---|---|---|---|---|
|
| ||||||
| Modality | Variable | Level | ||||
| PET | SUVmax (Baseline) | 72 (25) | 0.98 | [0.93 – 1.04] | 0.52 | |
| SUVmax (PreOp) | 72 (25) | 1.02 | [0.97 – 1.07] | 0.50 | ||
| PET Response (continuous) | 72 (25) | 1.00 | [0.99 – 1.00] | 0.14 | ||
| SUVmax Response (Median Cut) | < 32.5% | 36 (15) | 1.88 | [0.84–4.18] | 0.12 | |
| ≥ 32.5% | 36 (10) | REF | ||||
| SUVmax (Published Cut) | < 35% | 38 (16) | 1.99 | [0.88 – 4.52] | 0.10 | |
| ≥ 35% | 34 (9) | REF | ||||
|
| ||||||
| Pathology | T Stage | T0–T1b | 19 (2) | REF | ||
| T2 | 11 (1) | 0.77 | [0.07 – 8.52] | 0.83 | ||
| T3–T4 | 42 (22) | 6.69 | [1.57 – 28.50] | 0.010 | ||
| Overall Stage | 0–I | 21 (2) | REF | |||
| II | 26 (4) | 1.96 | [0.36 – 10.70] | 0.44 | ||
| III–IV | 25 (19) | 15.2 | [3.51 – 65.89] | 0.0003 | ||
| N Stage | N0 | 31 (3) | REF | |||
| N1+ | 41 (22) | 8.30 | [2.48 – 27.81] | 0.0006 | ||
| Pathologic Responseˆ | 72 (25) | 0.86 | [0.77 – 0.97] | 0.016 | ||
| < 35% | 36 (16) | 2.20 | [0.97 – 4.98] | 0.06 | ||
| ≥ 35% | 36 (9) | REF | ||||
| LVI | No | 32 (4) | REF | |||
| Yes | 40 (21) | 5.30 | [1.81 – 15.47] | 0.002 | ||
ˆ
HR in increments of 10 units